Cardiology Topic Homepage

Learning Zones

,Adipositas-Lernzentrum

Das Adipositas-Lernzentrum enthält klinische Informationen und Materialien für Gesundheitsexperten, die mit der Behandlung und dem Management von adipösen oder übergewichtigen Patienten befasst sind.

Hier finden Sie ein Wissenszentrum mit Informationen über die Epidemiologie, Pathophysiologie, klinischen Leitlinien, Bewertungs- und Behandlungsoptionen, Präventionsmethoden u. v. m. Andere Bereiche des Lernzentrums beinhalten eine Bibliothek klinischer Medien, neueste Nachrichten und Artikel aus Fachzeitschriften, Informationen über Veranstaltungen, Leitfäden für Patienten sowie die EACCME-akkreditierte CME-Reihe der europäischen Adipositas-Initiative, mit der insgesamt fünf europäische CME-Fortbildungspunkte (ECMECs) erworben werden können.

,Obesity learning hub header ES

El Centro de aprendizaje sobre obesidad contiene información clínica y recursos para profesionales sanitarios que intervienen en el tratamiento y el manejo de pacientes con obesidad o sobrepeso.
Aquí encontrará un Centro de conocimientos con información sobre epidemiología, fisiopatología, directrices clínicas, opciones de tratamiento y evaluación, métodos de prevención y más. Otras secciones del Centro de aprendizaje incluyen una mediateca clínica, noticias y artículos de revistas, información sobre eventos, guías para pacientes y una serie de EMC de la Iniciativa Europea para la Obesidad acreditada por el EACCME que equivale a un total de cinco créditos de EMC europeos.
 

,

Qui troverai un Centro didattico con informazioni su epidemiologia, patofisiologia, linee guide cliniche, opzioni terapeutiche e di valutazione, metodi di prevenzione e tanto altro. Le altre sezioni del Centro di apprendimento comprendono una mediateca clinica, notizie e articoli di giornali, informazioni su eventi, guide per i pazienti e la serie CME European Obesity Initiative accreditata dall’EACCME che vale un totale di cinque crediti ECM europei (ECMEC).

,Obesity LH Portuguese header

​A Plataforma de Aprendizagem sobre Obesidade contém informações clínicas e recursos para profissionais de saúde envolvidos no tratamento e na gestão de doentes obesos ou com excesso de peso.

Encontrará aqui um Centro de Conhecimento com informações sobre epidemiologia, patofisiologia, orientações clínicas, opções de avaliação e tratamento, métodos de prevenção e mais. Outras secções da Plataforma de Aprendizagem incluem uma mediateca clínica, notícias e artigos de publicações especializadas, informações sobre eventos, guias do doente e a série de FMC da Iniciativa Europeia sobre Obesidade, acreditada pelo EACCME, que equivale a um total de cinco créditos europeus de FMC (ECMEC).
,

The Anti-Coagulation Video Channel* is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with atrial fibrillation (AF) or venous thromboembolism (VTE). It provides an overview of how to prevent stroke and systemic embolism in nonvalvular AF patients and how to prevent and treat VTE.

Users can expect to find the following videos readily available on the video channel with regular updates:

  • The benefits of dabigatran in preventing stroke in atrial fibrillation patients
    (Hans-Christoph Diener, Gregory YH Lip and John Eikelboom)
  • Dabigatran for the treatment and prevention of DVT and PE
    (Samuel Z Goldhaber)
  • The safety profile of dabigatran
    (Hans-Christoph Diener, John Eikelboom and Jeffrey Weitz)

Healthcare professionals should return often to avoid missing out on new content.

*The Anti-Coagulation Video Channel has been supported by an educational grant from Boehringer Ingelheim, who provided the videos, and is intended for healthcare professionals outside the USA, Canada and UK.

,Thrombosis Educational Portal

The Thrombosis Educational Portal is intended for healthcare professionals involved in the treatment and management of venous and arterial thrombosis. This resource is organised around the following sections:

  • Thrombosis
  • VTE Prevention
  • VTE Treatment
  • Atrial Fibrillation
  • Acute Coronary Syndrome (ACS)

Users will also have access to a newsletters section, which is updated on a quarterly basis with related thrombosis news content. The most recent edition from February 2015 contains an article written by Professor John Camm, Professor of Clinical Cardiology at St George’s, University of London and Imperial College London titled ‘Extending the Clinical Utility of Novel Oral Anticoagulants’.

This resource is intended to provide information to an international audience outside of the UK and the USA.

,Obesity Learning Hub

The Obesity Learning Hub contains clinical information and resources for healthcare professionals involved in the treatment and management of obese or overweight patients.

Here you will find a Knowledge Centre with information on epidemiology, pathophysiology, clinical guidelines, assessment and treatment options, prevention methods and more. Other sections within the Learning Hub include a clinical media library, news and journal articles, events information, patient guides and the EACCME-accredited European Obesity Initiative CME series, which is worth five European CME Credits (ECMECs) in total.

,

This educational resource contains a range of content developed for healthcare professionals based in Europe who are involved in the treatment and management of type 2 diabetes mellitus. In this section you will find:

Type 2 Diabetes Mellitus Knowledge Centre: Provides epidemiology statistics, current diagnostic criteria from WHO and ADA, treatment options and a section containing the latest guidelines.

Therapy Focus: Compiles material on emerging insulin/incretin treatment combinations arranged across five informative sections.

Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin CME activityEACCME-accredited CME activity worth 1 European CME credit (ECMEC).

‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’ CME activityincludes an expert panel discussion video.

,Obesity series

This EACCME-accredited obesity CME series contains three CME modules, which are ideal for healthcare professionals looking to improve their understanding of obesity as a serious medical illness.

Module 1 – Understanding Obesity
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy.

Module 2 – Considerations for Individualising Pharmacotherapy
Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care.

Module 3 – Rationale for Lifelong Behaviour Change
Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy.

Upon successful completion of these modules, participants will receive a combined total of five European CME credits (ECMECs).

Clinical Case Studies

MRSA Endocarditis

Infection: Cardiovascular Infections

Christopher D. Pfeiffer, Clinical Fellow, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Vance Fowler, Associate Professor and Infectious Diseases, Specialist, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA

Case History
A 64-year-old female presented with three weeks of progressive dyspnoea, nausea and vomiting.

Vascular Graft Infection

Infection: Cardiovascular Infections

Stephanie J. Dancer BSc, MB BS, MSc, MD, FRCPath, DTM&H, Consultant Microbiologist, NHS Lanarkshire, Scotland

Case History
A 72-year-old man was referred by his general practitioner complaining of intermittent pain in the legs on exercise.

Latest News

Medical Videos

Advances in Dual Antiplatelet Therapy for Acute Coronary Syndrome (ACS)
Advances in Dual Antiplatelet Therapy for Acute Coronary Syndrome (ACS)
The Lead: Time to Abandon LDL Treatment Targets?
The Lead: Time to Abandon LDL Treatment Targets?
A Guide to the Coronary Angioplasty Procedure
A Guide to the Coronary Angioplasty Procedure
Animation: New therapy prevents heart failure
Animation: New therapy prevents heart failure
3D Medical Animation - Congestive Heart Failure
3D Medical Animation - Congestive Heart Failure
A Discussion of Interventional Cardiology and the Procedures Involved
A Discussion of Interventional Cardiology and the Procedures Involved

Recent Drug Updates

Medical Journal Abstracts on Cardiology

Ivabradine in Management of Heart Failure: a Critical Appraisal.

Thu 21 Jan 2016 -  Ivabradine in Management of Heart Failure: a Critical Appraisal.

Elevated resting heart rate has been linked to poor outcomes in patients with chronic systolic heart failure. Blockade of funny current channel with ivabradine reduces heart rate without inotropic ...

A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223.

Thu 21 Jan 2016 -  A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223.

Aims: Sustained cardiac hypertrophy accompanied by maladaptive cardiac remodelling represents an early event in the clinical course leading to heart failure. Maladaptive hypertrophy is considered to ...

Clinical Guidelines

2015 ESC Guidelines for the management of infective endocarditis

Aug 2015

Infective endocarditis (IE) is a deadly disease. Despite improvements in its management, IE..

... remains associated with high mortality and severe complications. Until recently, guidelines on IE were mostly based on expert opinion because of the low incidence of the disease, the absence of randomized trials and the limited number of meta-analyses.

The 2009 ESC Guidelines on the prevention, diagnosis and treatment of IE8 introduced several innovative concepts, including limitation of antibiotic prophylaxis to the highest-risk patients, a focus on healthcare-associated IE and identification of the optimal timing for surgery. However, several reasons justify the decision of the ESC to update the previous guidelines: the publication of new large series of IE, including the first randomized study regarding surgical therapy; important improvements in imaging procedures, particularly in the field of nuclear imaging; and discrepancies between previous guidelines. In addition, the need for a collaborative approach involving primary care physicians, cardiologists, surgeons, microbiologists, infectious disease (ID) specialists and frequently other specialists— namely the ‘Endocarditis Team’—has been underlined recently and will be developed in these new guidelines.

The main objective of the current Task Forcewas to provide clear and simple recommendations, assisting healthcare providers in their clinical decision making. These recommendations were obtained by expert consensus after thorough review of the available literature. An evidence-based scoring system was used, based on a classification of the strength of recommendations and the levels of evidence.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Aug 2015

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple clinical..

... conditions and can complicate the majority of cardiovascular and respiratory diseases. The composition of the guidelines task force reflects themultidisciplinary nature of PH, including members of different medical societies, associations and working groups. The current document follows the two previous ESC and ERS Guidelines, published in 2004 and 2009, focusing on clinical management of PH. A systematic literature review was performed from MEDLINEw to identify new studies published since 2009 concerning the topic of PH. Task force members selected studies based on relevance and appropriateness.

Online CME

Considerations for Individualising Pharmacotherapy

Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care. EACCME accredited.

Understanding Obesity

Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy....

Rationale for Lifelong Behavioural Change

Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy. EACCME accredited.

Clinical Trials

Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease (DCB-SFA)

-110 days ago

This study evaluates the safety and effectiveness of percutaneous transluminal angioplasty (PTA) using drug-coated balloons for the treatment of superficial femoral and popliteal peripheral artery ...

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event (TRANSITION)

-18 days ago

To explore two modalities of treatment initiation (Pre-discharge, and Post-discharge) with LCZ696 in HFrEF patients following stabilization after an ADHF ...

Back to top